Pharmaceutical Technology

JUNE 15, 2023

Pharma R&D teams are solving this problem by leveraging the power of artificial intelligence (AI) in clinical trials to save time and money. Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Food and Drug Administration approval.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

pharmaphorum

FEBRUARY 4, 2022

. “This way, the control group does not need to recruit patients, which also increases the cost-efficiency of drug development,” according to Aalto’s Prof Harri Lähdesmäki, who also works within the Finnish Center for Artificial Intelligence (FCAI).

Trials 69

Trials Clinical Trials Clinical Trials Pharma Companies 69

pharmaphorum

SEPTEMBER 27, 2021

As the vaccines were developed and rolled out, the disparity in their take up among different sections of the community highlighted how excluded some minority communities felt from areas of healthcare. In 2020, 53 novel medicines were approved by the FDA and of the patients who took part in trials, just 8% were black and 6% were Asian.

Clinical Trials 122

Clinical Trials Clinical Trials Trials Vaccination 122